How HSV Actually Works
⏱️ 7 min readThis article is for informational purposes only and is not a substitute for medical advice. Talk to a healthcare provider about your specific situation.
- HSV lives in nerve tissue and becomes dormant between episodes — which is why it stays in the body long-term, unlike a short-lived cold or flu.
- Episodes follow a recognizable pattern: a prodrome phase, a short active phase, and full healing — usually within 7–10 days.
- Where episodes appear depends on where the virus entered the body — oral exposure leads to oral episodes, genital to genital, though either type can appear in either location.
- Asymptomatic shedding — when the virus surfaces with no visible symptoms — is how most transmissions happen; daily antiviral medication meaningfully reduces it.
If you’ve been diagnosed with herpes, you may have questions about the virus and how it works. This article goes into detail about HSV, aka herpes-simple-virus, and what to expect if you have it. With more understanding, you should be able to manage it better.
How HSV is contracted
Herpes spreads through direct skin-to-skin contact — specifically, contact with an area of skin where the virus is active. This can happen whether or not visible sores are present.
Oral HSV (most often HSV-1) is typically transmitted through kissing, oral-to-oral contact, or oral sex. Many people contract HSV-1 in childhood through normal family interactions, e.g. a kiss on the cheek from mom, etc.
Genital HSV (most often HSV-2, though HSV-1 can also establish itself genitally) is transmitted through genital-to-genital or oral-to-genital sexual contact.
In both cases, the point of entry determines where the virus settles. Oral exposure leads to oral HSV; genital exposure leads to genital HSV. Either type can establish itself in either location depending on the nature of the contact. Caveat: oral HSV-2 is very rare.
What HSV does not spread through: toilet seats, towels, water, or casual contact like hugging or sharing a meal. The virus doesn’t survive outside the body and requires direct skin contact to pass between people.
One important nuance: most transmissions happen when no visible symptoms are present — a phenomenon called asymptomatic shedding, covered in more detail below.
How HSV Lives in the Body
Once herpes enters the body, it travels to clusters of nerve cells called ganglia — the trigeminal ganglia (near the base of the skull) for oral herpes, the sacral ganglia (at the base of the spine) for genital HSV. There, it goes quiet.
In its dormant state, the virus isn’t replicating or causing symptoms — it’s just chilling in the nerve tissue. Herpes targets nerve tissue because the immune system has limited reach there.
Periodically, it reactivates, traveling back down the nerve pathway to the skin surface. Sometimes that causes a visible episode, but usually it doesn’t. We call when the virus reactivates without any visible symptoms “asymptomatic shedding” or an “asymptomatic episode.”
Episode Timeline
Not everyone experiences episodes the same way, but there’s a consistent pattern.
The prodrome
Many people notice early signals before anything visible appears — usually felt at or near the site where episodes occur:
- Tingling, itching, or burning at the site
- Mild pressure or skin sensitivity in the area
- Fatigue, lower back ache, or generally feeling unwell (more common with genital HSV)
The prodrome typically lasts a few hours to a couple of days and becomes more recognizable over time. For most people it’s a reliable heads-up to start antiviral medication early.
Active phase and timeline
The active phase of a recurrent episode typically runs 3–5 days; full healing usually completes within 7–10. Antiviral medication shortens this window.
First episode vs. recurrences
The first episode is often the most significant — more pronounced, potentially lasting up to two weeks, sometimes with flu-like symptoms as the immune system mounts its initial response. Recurrent episodes tend to be shorter, milder, and more predictable. Many people experience fewer over time; some stop having noticeable episodes altogether.
What Outbreaks Look Like
When an episode becomes visible, it tends to follow a recognizable visual progression.
Small blisters form — usually clustered together, fluid-filled, and ranging from barely noticeable to mildly tender. The skin around them may look red or slightly inflamed. Over the next few days, the blisters break open and become shallow, open sores. These then crust over and heal gradually from the outer edges inward.
For oral herpes, this most often appears on or around the lips, the corners of the mouth, or the lower face. For genital herpes, sores typically appear on the genitals, inner thighs, or buttocks — the areas supplied by the sacral nerve.
Severity varies. Some episodes are pronounced enough to be uncomfortable; others are subtle enough to be mistaken for an ingrown hair or minor irritation. First episodes tend to be more significant; recurrences are usually mild.
Asymptomatic Shedding
This is one of the most important things to understand — and one of the most confusing. Shedding is when the virus briefly reactivates and reaches the skin surface without causing visible symptoms. No sores, no prodrome, nothing you’d notice — and yet the virus can be passed during those moments. Experts theorize, this is how most herpes transmissions actually happen.
- Shedding tends to be more frequent in the first year after initial exposure, and decreases over time
- HSV-2 sheds more frequently than HSV-1, particularly in the genital region
- Daily antiviral medication significantly reduces shedding — even on symptom-free days — which is one of the main reasons people choose it
Not sure if you’ve been exposed? Understanding your testing options is a good place to start.
What HSV Is and Isn’t Linked To
A lot of health anxiety around herpes comes from things it isn’t actually connected to. The most common ones, debunked.
Cancer. HSV is often confused with HPV— they’re completely different viruses. HPV is the one associated with certain cancers. HSV is not linked to cancer of any kind.
HIV. Having HSV doesn’t mean you have HIV, and one doesn’t cause the other. That said: HSV-2 is associated with a higher likelihood of acquiring HIV if exposed — roughly 2–3x — due to the entry points that active sores create and ongoing inflammation between episodes. [Looker et al., 2017]
Infertility. Herpes has no established link to fertility complications for most people. There are specific conversations worth having with a clinician around the time of delivery if pregnancy is part of your picture — but that’s targeted, not a blanket concern.
The Alzheimer’s research
Over the past decade, research has examined whether HSV-1 may play a role in Alzheimer’s disease — specifically, whether its presence in nerve tissue near the brain might contribute to the neuroinflammation associated with Alzheimer’s.
The headline finding: people who received antiviral treatment after an HSV diagnosis were significantly less likely to develop dementia than those who weren’t treated [Tzeng et al., Neurotherapeutics 2018]. Observational data, not a controlled trial — but a notable signal. The association is primarily with HSV-1, and clinical guidelines haven’t changed. For those already on daily antivirals, there may be an incidental long-term benefit worth knowing about.
What This Means for You
Understanding how herpes behaves — dormancy, episodes, shedding — takes a lot of the uncertainty out of the picture.
Episodes become something you can read, with their own early signals and a predictable timeline. Shedding becomes something you can actively reduce. The virus stays in nerve tissue, but your day-to-day life doesn’t have to revolve around it.
Most people, once they understand the mechanics, feel more in control than they expected. That’s what this is for.
Want Support? Join our waitlist to be among the first to connect with Harper’s specialized team when we launch. Join the waitlist →
Sources
- CDC — Herpes Simplex Virus (HSV)
- Looker KJ et al. “Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.” Lancet Infect Dis, 2017. PubMed
- Tzeng N-S et al. “Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections.” Neurotherapeutics, 2018. PMC